TFMG
4 years ago
$MGEN | #MiragenTherapeutics, Inc 30% Upside
Miragen Therapeutics , Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma; and remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Boulder, CO.
whytestocks
4 years ago
JUST IN: $MGEN miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
Acquisition includes clinical stage anti-IGF - 1R monoclonal antibody, VRDN-001 , intended for the treatment of thyroid eye disease (TED) Company plans to use p rivate placement financing p roceeds of $ 91 million to advance mu...
Find out more MGEN - miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.